Compugen (CGEN) EBITDA (2009 - 2026)

Compugen has reported EBITDA for 18 years, with the latest figure at $9.0 million in Q1 2026.

• EBITDA for Q1 2026 came in at $9.0 million, up 7.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $31.9 million (up 313.16% YoY), and the FY2025 annual result was $31.3 million, up 310.37% from the prior year.
• EBITDA eased to $9.0 million in Q1 2026, from $56.0 million in the prior quarter.
• Over five years, EBITDA peaked at $56.0 million in Q4 2025 and troughed at -$30.5 million in Q2 2023.
• A 5-year average of $916058.8 and a median of -$3.5 million in 2022 frame the typical range for EBITDA.
• The largest YoY upside for EBITDA was 848.94% in 2025 against a maximum downside of 275.56% in 2025.
• A 5-year view of EBITDA shows it stood at -$3.5 million in 2022, then surged by 609.61% to $18.0 million in 2023, then tumbled by 141.61% to -$7.5 million in 2024, then surged by 848.94% to $56.0 million in 2025, then slumped by 83.91% to $9.0 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $9.0 million in Q1 2026, $56.0 million in Q4 2025, and -$7.9 million in Q3 2025.